Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ironwood Pharmaceuticals (IRWD) Cost of Revenue (2017 - 2020)

Ironwood Pharmaceuticals' Cost of Revenue history spans 7 years, with the latest figure at $897000.0 for Q4 2020.

  • On a quarterly basis, Cost of Revenue fell 91.86% to $897000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $3.1 million, a 86.86% decrease, with the full-year FY2020 number at $3.1 million, down 86.86% from a year prior.
  • Cost of Revenue hit $897000.0 in Q4 2020 for Ironwood Pharmaceuticals, down from $2.2 million in the prior quarter.
  • Over the last five years, Cost of Revenue for IRWD hit a ceiling of $21.5 million in Q4 2018 and a floor of $506000.0 in Q3 2019.
  • Historically, Cost of Revenue has averaged $5.6 million across 4 years, with a median of $3.8 million in 2017.
  • Biggest five-year swings in Cost of Revenue: surged 390.96% in 2018 and later plummeted 91.86% in 2020.
  • Tracing IRWD's Cost of Revenue over 4 years: stood at $9.0 million in 2017, then soared by 138.9% to $21.5 million in 2018, then crashed by 48.69% to $11.0 million in 2019, then plummeted by 91.86% to $897000.0 in 2020.
  • Business Quant data shows Cost of Revenue for IRWD at $897000.0 in Q4 2020, $2.2 million in Q1 2020, and $11.0 million in Q4 2019.